(Q64676050)
Statements
IMPRES (English)
0 references
A 24-week Randomized Placebo-controlled, Double-blind Multi-center Clinical Trial Evaluating the Efficacy and Safety of Oral QTI571 as an add-on Therapy in the Treatment of Severe Pulmonary Arterial Hypertension: Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES) (English)
0 references
September 2009
0 references
May 2011
0 references
202
0 references
18 year
0 references